| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |